-
Nrx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing Of A Citizen Petition With The US Food And Drug Administration Seeking Removal Of Benzethonium Chloride From Ketamine Products
04 Aug 2025 13:06 GMT
… Citizen Petition with the US Food and Drug Administration (FDA), seeking the removal of Benzethonium … manufacture, while it awaits generic approval. The Company is additionally seeking … file an NDA for Accelerated Approval for NRX-101 in patients …
-
Innovent Receives U.S. FDA Approval For IND Application Of Oral GLP-1R Agonist IBI3032
05 Aug 2025 01:01 GMT
… that the U.S. Food and Drug Administration (FDA) has approved the investigational new drug ( … into clinical development. This IND approval reflects Innovent's strong … (NMPA) and approved by the U.S. Food and Drug Administration (FDA). A multi-regional …
-
FDA Approves Application for ABT-301 in Metastatic Colorectal Cancer
04 Aug 2025 21:37 GMT
The U.S. Food and Drug Administration (FDA) has approved an investigational new drug application … newsletters here.
References
“Anbogen Receives FDA Clearance to Initiate Phase 1 …
-
FDA Clears Anbogen’s Oral HDAC1/2/3 Inhibitor for Phase I/II Colorectal Trial
05 Aug 2025 00:12 GMT
… Secured: Anbogen Therapeutics receives FDA approval to start Phase I … development and commercialization.
The FDA has granted Anbogen Therapeutics … 1
References
Anbogen Receives FDA Clearance to Initiate … /anbogen-receives-fda-clearance-to-initiate-phase …
-
FDA Addresses Opioid Medication Safety With Additional Label Changes
04 Aug 2025 21:02 GMT
… need to modernize our approval processes and post-market … , as there are no FDA-approved 7-OH drugs.1
In … threatening American consumers. News release. FDA. July 29, 2025. Accessed … products-threatening-american-consumers
3. FDA. 7-hydroxymitragynine (7-OH): …
-
FDA Greenlights Novel Colorectal Cancer Triplet Therapy Trial
04 Aug 2025 20:25 GMT
Anbogen Therapeutics has received US FDA approval for its investigational new drug ( … in mCRC.
With the FDA's IND approval, Anbogen Therapeutics is … -301.
REFERENCES:
1. Anbogen Receives FDA Clearance to Initiate Phase 1 …
-
Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia
04 Aug 2025 20:01 GMT
… the first country to approve PYRUKYND for the treatment … . Food and Drug Administration is September 7, 2025. PYRUKYND is also approved for … Agios’ expectations for the FDA’s review of its sNDA … and maintain requisite regulatory approvals and to enroll patients …
-
Replimune (REPL) Faces Securities Class Action Following Stock’s Collapse Amid FDA’s Rejection of Melanoma Drug - Hagens Berman
04 Aug 2025 19:53 GMT
… the company announced that the Food and Drug Administration (FDA) had rejected its application for … Therapy designation by the FDA, its Accelerated Approval pathway, and assurances … approve the application in its present form." More critically, the FDA …
-
FDA Mandates Changes to Opioids Labeling
04 Aug 2025 19:34 GMT
… Key Takeaways:
FDA-mandated label changes: The FDA is requiring … need to modernize our approval processes and post-market … for OxyContin was initially approved without study data supporting … data from two large FDA-required observational studies, called …
-
FDA updates opioid pain medication labeling requirements
04 Aug 2025 19:18 GMT
… needs to be done," FDA Commissioner Marty Makary, M. … press release, adding that drug approval and post-market monitoring processes … epidemic.
Required labeling updates
The FDA's opioid safety … use.
Industry impact
The FDA says it has sent letters …